M
Maat Pharma SA
PAR:MAAT
Maat Pharma SA
PAR:MAAT
Price:
7.5
EUR
-3.6%
Market Closed
Market Cap:
€140.6m
Cash Flow Statement
Cash Flow Statement
Maat Pharma SA
Maat Pharma SA
Currency: EUR
| Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||
| Net Income |
(12)
|
(14)
|
(15)
|
(20)
|
(24)
|
(29)
|
(31)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
1
|
2
|
2
|
2
|
|
| Stock-Based Compensation |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
|
| Other Non-Cash Items |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
(0)
|
(5)
|
(0)
|
3
|
3
|
3
|
|
| Cash from Operating Activities |
(11)
N/A
|
(13)
-17%
|
(18)
-46%
|
(19)
-1%
|
(19)
-2%
|
(22)
-16%
|
(24)
-10%
|
|
| Investing Cash Flow | ||||||||
| Capital Expenditures |
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Other Items |
(0)
|
(0)
|
0
|
1
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(1)
-256%
|
(1)
-15%
|
(0)
+53%
|
(0)
+55%
|
(0)
-108%
|
(0)
-19%
|
|
| Financing Cash Flow | ||||||||
| Net Issuance of Common Stock |
32
|
(0)
|
13
|
13
|
17
|
17
|
12
|
|
| Net Issuance of Debt |
2
|
6
|
5
|
(4)
|
(2)
|
2
|
(4)
|
|
| Other |
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Cash from Financing Activities |
34
N/A
|
5
-84%
|
16
+197%
|
8
-49%
|
15
+86%
|
18
+21%
|
8
-55%
|
|
| Change in Cash | ||||||||
| Net Change in Cash |
23
N/A
|
(8)
N/A
|
(3)
+57%
|
(11)
-218%
|
(4)
+63%
|
(4)
-2%
|
(16)
-299%
|
|
| Free Cash Flow | ||||||||
| Free Cash Flow |
(11)
N/A
|
(13)
-23%
|
(20)
-48%
|
(20)
-1%
|
(20)
+0%
|
(23)
-16%
|
(25)
-10%
|
|
Switch to:
Switch to:
See Also
Discover More
